INS and metabolic disease: In particular, established diabetic nephropathy treatments, including angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, insulin therapy, and metabolic disorder medications, have been investigated for their potential roles in modulating ferroptotic processes.